EF
CRL icon

Empowered Funds’s Charles River Laboratories CRL Stock Holding History

Empowered Funds’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Sell
2,495
-642
-20% -$114K ﹤0.01% 1633
2026
Q1 		$541K Buy
+3,137
New +$582K ﹤0.01% 1623
2025
Q4 		– Sell
-4,916
Closed -$769K – 1204
2025
Q3 		$769K Buy
4,916
+308
+7% +$48.9K 0.01% 1254
2025
Q2 		$699K Buy
4,608
+1,832
+66% +$244K 0.01% 1205
2025
Q1 		$418K Buy
+2,776
New +$465K 0.01% 1288
2024
Q3 		– Sell
-3,764
Closed -$778K – 1408
2024
Q2 		$778K Buy
3,764
+420
+13% +$95.2K 0.01% 934
2024
Q1 		$906K Buy
3,344
+304
+10% +$72.6K 0.02% 915
2023
Q4 		$719K Buy
3,040
+535
+21% +$105K 0.02% 895
2023
Q3 		$491K Buy
2,505
+75
+3% +$15.4K 0.01% 926
2023
Q2 		$511K Sell
2,430
-94
-4% -$18.7K 0.02% 815
2023
Q1 		$509K Buy
+2,524
New +$572K 0.03% 392
2022
Q4 		– Sell
-2,138
Closed -$467K – 477
2022
Q3 		$421K Buy
+2,138
New +$462K 0.04% 267
2022
Q1 		– Sell
-4,888
Closed -$1.84M – 253
2021
Q4 		$1.84M Buy
+4,888
New +$1.9M 0.21% 112
2018
Q1 		– Sell
-9,241
Closed -$1.01M – 99
2017
Q4 		$1.01M Buy
+9,241
New +$1.01M 0.51% 48

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Empowered Funds's CRL Position: Q2 2026 in Review

Empowered Funds reduced its Charles River Laboratories (CRL) stake by 20% in Q2 2026, selling an estimated $114K and leaving 2,495 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Empowered Funds first reported a position in CRL in Q4 2017 and has held it in 14 quarters since. The position peaked at $1.84M in Q4 2021. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Empowered Funds held 2,495 shares of Charles River Laboratories worth $566K as of Q2 2026.
  • Empowered Funds sold 642 Charles River Laboratories shares in Q2 2026, an estimated $114K.
  • Charles River Laboratories made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1633 holding.
  • Empowered Funds first reported a position in Charles River Laboratories in Q4 2017 and has held it in 14 quarters since.
  • Empowered Funds's Charles River Laboratories position peaked at $1.84M in Q4 2021.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.